Literature DB >> 21177351

Recent advances in the management of rheumatoid arthritis.

Naomi B Klarenbeek1, Pit J S M Kerstens, Tom W J Huizinga, Ben A C Dijkmans, Cornelia F Allaart.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21177351     DOI： 10.1136/bmj.c6942

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  15 in total

1.  [EULAR recommendations for patient education of people with inflammatory arthritis. Translation and evaluation in Germany].

Authors:  J Patermann; I Ehlebracht-König; G Lind-Albrecht; E Genth; A Reusch; R Küffner; U Müller-Ladner; J Braun
Journal:  Z Rheumatol       Date:  2016-03       Impact factor: 1.372

2.  Role overload, pain and physical dysfunction in early rheumatoid or undifferentiated inflammatory arthritis in Canada.

Authors:  Sally Sabry Mustafa; Karl Julian Looper; Phyllis Zelkowitz; Margaret Purden; Murray Baron
Journal:  Biopsychosoc Med       Date:  2012-05-03

3.  Notch signaling mediates TNF-α-induced IL-6 production in cultured fibroblast-like synoviocytes from rheumatoid arthritis.

Authors:  Zhijun Jiao; Wenhong Wang; Jie Ma; Shengjun Wang; Zhaoliang Su; Huaxi Xu
Journal:  Clin Dev Immunol       Date:  2011-12-08

4.  Enhanced neutrophil phagocytic capacity in rheumatoid arthritis related to the autoantibodies rheumatoid factor and anti-cyclic citrullinated peptides.

Authors:  Marcelo Bogliolo Piancastelli de Siqueira; Licia Maria Henrique da Mota; Shirley Claudino Pereira Couto; Maria Imaculada Muniz-Junqueira
Journal:  BMC Musculoskelet Disord       Date:  2015-06-30       Impact factor: 2.362

5.  Ras Signaling Inhibitors Attenuate Disease in Adjuvant-Induced Arthritis via Targeting Pathogenic Antigen-Specific Th17-Type Cells.

Authors:  Morad Zayoud; Victoria Marcu-Malina; Einav Vax; Jasmine Jacob-Hirsch; Galit Elad-Sfadia; Iris Barshack; Yoel Kloog; Itamar Goldstein
Journal:  Front Immunol       Date:  2017-07-07       Impact factor: 7.561

6.  Does intensive management improve remission rates in patients with intermediate rheumatoid arthritis? (the TITRATE trial): study protocol for a randomised controlled trial.

Authors:  Naomi H Martin; Fowzia Ibrahim; Brian Tom; James Galloway; Allan Wailoo; Jonathan Tosh; Heidi Lempp; Louise Prothero; Sofia Georgopoulou; Jackie Sturt; David L Scott
Journal:  Trials       Date:  2017-12-08       Impact factor: 2.279

Review 7.  Classical and Paradoxical Effects of TNF-α on Bone Homeostasis.

Authors:  Bilal Osta; Giulia Benedetti; Pierre Miossec
Journal:  Front Immunol       Date:  2014-02-13       Impact factor: 7.561

8.  Tumour necrosis factor inhibitors versus combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis: TACIT non-inferiority randomised controlled trial.

Authors:  David L Scott; Fowzia Ibrahim; Vern Farewell; Aidan G O'Keeffe; David Walker; Clive Kelly; Fraser Birrell; Kuntal Chakravarty; Peter Maddison; Margaret Heslin; Anita Patel; Gabrielle H Kingsley
Journal:  BMJ       Date:  2015-03-13

9.  Two-Year Safety and Efficacy Experience in Patients with Methotrexate-Resistant Active Rheumatoid Arthritis Treated with Etanercept and Conventional Disease-Modifying Anti-rheumatic Drugs in the Latin American Region.

Authors:  Daniel A Machado; Renato Guzman; Ricardo M Xavier; Jesus A Simon; Linda Mele; Qi Shen; Ronald Pedersen; Sameer Kotak; Bonnie Vlahos
Journal:  Open Rheumatol J       Date:  2016-02-29

10.  A multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of Tong Luo Hua Shi capsule, a modernized Tibetan medicine, in patients with rheumatoid arthritis.

Authors:  Wei Liu; Yuan-Hao Wu; Si-Yuan Hu; Cheng-Liang Zhong; Ming-Li Gao; Dong-Wu Liu; Hai-Yun Wang; Mu-Zhi Chen; Yue-Jin Song; Ben-Zha-Xi Yang; Qing-Shan Zheng; Hua Yao; Xue-Bing Qi; Gang Li
Journal:  Trials       Date:  2016-07-27       Impact factor: 2.279
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.